Annovis Bio, Inc. (ANVS)

Annovis Bio Statistics

Total Valuation

Annovis Bio has a market cap or net worth of $60.09 million. The enterprise value is $42.63 million.

Market Cap	60.09M
Enterprise Value	42.63M

Important Dates

The next estimated earnings date is Tuesday, May 12, 2026.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Annovis Bio has 34.53 million shares outstanding. The number of shares has increased by 67.97% in one year.

Current Share Class	34.53M
Shares Outstanding	34.53M
Shares Change (YoY)	+67.97%
Shares Change (QoQ)	+29.94%
Owned by Insiders (%)	13.92%
Owned by Institutions (%)	15.23%
Float	29.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.92
P/TBV Ratio	3.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.80

Current Ratio	5.80
Quick Ratio	5.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -220.61% and return on invested capital (ROIC) is -141.90%.

Return on Equity (ROE)	-220.61%
Return on Assets (ROA)	-106.03%
Return on Invested Capital (ROIC)	-141.90%
Return on Capital Employed (ROCE)	-170.21%
Weighted Average Cost of Capital (WACC)	11.75%
Revenue Per Employee	n/a
Profits Per Employee	-$4.12M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.23% in the last 52 weeks. The beta is 1.36, so Annovis Bio's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	+15.23%
50-Day Moving Average	2.30
200-Day Moving Average	2.69
Relative Strength Index (RSI)	37.77
Average Volume (20 Days)	1,311,491

Short Selling Information

The latest short interest is 3.23 million, so 9.37% of the outstanding shares have been sold short.

Short Interest	3.23M
Short Previous Month	2.75M
Short % of Shares Out	9.37%
Short % of Float	10.88%
Short Ratio (days to cover)	7.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.70M
Pretax Income	-28.85M
Net Income	-28.85M
EBITDA	n/a
EBIT	-29.70M
Earnings Per Share (EPS)	-$1.40

Balance Sheet

The company has $19.53 million in cash and n/a in debt, with a net cash position of $19.53 million or $0.57 per share.

Cash & Cash Equivalents	19.53M
Total Debt	n/a
Net Cash	19.53M
Net Cash Per Share	$0.57
Equity (Book Value)	16.85M
Book Value Per Share	0.62
Working Capital	17.45M

Cash Flow

Operating Cash Flow	-25.62M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Annovis Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-67.97%
Shareholder Yield	-67.97%
Earnings Yield	-46.42%
FCF Yield	n/a

Analyst Forecast

The average price target for Annovis Bio is $13.50, which is 675.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.50
Price Target Difference	675.86%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2